We investigated the expression of EP4 in vulvar cancer, its correlation with clinicopathological parameters, its association with overall survival, and the effect oft EP4 antagonism on vulvar cancer cells, aiming to find a prognostic and potentially targetable marker in vulvar cancer. The gene discussed is PTGER4; the disease is vulva cancer.